Treatment of unresectable cutaneous squamous cell carcinoma with pembrolizumab

Currently, there are few effective therapies for locally advanced and metastatic cutaneous squamous cell carcinoma (cSCC); however, there is recent evidence supporting the use of immunological therapies in cSCC given the typically high mutation burden and association with immunosuppressed states. Th...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:BMJ Case Rep
Główni autorzy: Venkatesh, Samantha, Al-Haseni, Ali, Sahni, Debjani
Format: Artigo
Język:Inglês
Wydane: BMJ Publishing Group 2019
Hasła przedmiotowe:
Novel Treatment (New Drug/Intervention; Established Drug/Procedure in New Situation)
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6685369/
https://ncbi.nlm.nih.gov/pubmed/31377718
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2019-229915
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy